Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2008
10/15/2008CN100425699C scFvC6.5-TNF-alpha fusion gene and protein, and its preparation
10/15/2008CN100425697C Nucleotid sequence of human interleukin 21 and method and application of producing matured human interleukin 21
10/15/2008CN100425695C Novel human Rab GTP enzyme, its coding sequence and application
10/15/2008CN100425287C Tumor vaccines
10/15/2008CN100425286C Purified ustading and its preparation method and medicinal composition containing said ustading
10/15/2008CN100425285C Device having osteoinductive and osteoconductive properties
10/15/2008CN100425284C Methods for glucagon suppression
10/15/2008CN100425283C Stable pharmaceutical composition comprising erythropoietin
10/15/2008CN100425282C Y2/Y4 selective receptor agonists for therapeutic interventions
10/15/2008CN100425281C Technique for preparing injection of protein polyeptide
10/15/2008CN100425246C Anti-dust nasal cleanser
10/14/2008US7435869 Transgenic nonhuman mammals producing fibrinogen in milk and methods of producing fibrin
10/14/2008US7435802 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury
10/14/2008US7435798 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in normal stomach, normal skin and kidney tumor
10/14/2008US7435795 Stabilized hemoglobin solutions
10/14/2008US7435792 Hybrid proteins that migrate retrogradely and transynaptically into the CNS
10/14/2008US7435790 Dihydroxypropyl cysteine peptide and agent containing this peptide
10/14/2008US7435755 Inducing cytotoxicity in a cell comprising contacting with a CDDO-compound and a chemotherapeutic agent
10/14/2008US7435727 Incubating biomaterial with radiolabeled, photoreactive 2-azetidinone compound; solubilizing and forming eluent of supernatant and wheat germ lectin agarose; separating using column chromatography and gel electrophoresis
10/14/2008US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury
10/14/2008US7435721 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell
10/14/2008US7435720 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
10/14/2008US7435719 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
10/14/2008US7435718 CXCR4 antagonist treatment of hematopoietic cells
10/14/2008US7435717 Comprises doses of Apolipoprotein A-I Milano:phospholipid complex to reduce and stabilize atherosclerotic plaque; for treating ischemic reperfusion
10/14/2008US7435716 Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia
10/14/2008US7435595 Using prokaryotic histone protein as tool in transfer of heterologus nucleotide sequences into cells; improving exogenous gene expression
10/14/2008US7435549 Method of identifying binding site domains that retain the capacity of binding to an epitope
10/14/2008US7435540 Drug screening; prion disease; Creutzfeldt-Jakob disease; for detecting and for purifying PrPSc
10/14/2008US7435425 Dry hemostatic compositions and methods for their preparation
10/14/2008US7435421 Derivatives of choline binding proteins for vaccines
10/14/2008US7435419 Methods of diagnosing and treating pre-eclampsia or eclampsia
10/14/2008US7435418 Isolated polypeptide comprising a claimed amino acid sequence
10/14/2008US7435410 Methods of treatment with interferson and albumin fusion protein
10/14/2008US7435408 Porous particles comprising excipients for deep lung delivery
10/14/2008US7435380 Dispensed from a spray bottle
10/14/2008CA2339244C Methods of ophthalmic administration
10/14/2008CA2336139C Large porous particles emitted from an inhaler
10/14/2008CA2322380C Method of preventing the death of retinal neurons and treating ocular diseases
10/14/2008CA2300766C Neurotoxic component of botulinum toxin for treating cervical dystonia
10/14/2008CA2255865C Synthesis of soluble beta-sheet forming peptides
10/14/2008CA2192782C Production of microspheres
10/14/2008CA2190394C Recombinant viruses, preparation and use thereof in gene therapy
10/14/2008CA2185999C Treatment of congestive heart failure
10/14/2008CA2168584C A method for sensitization of cancer cells for killer cell mediated lysis
10/09/2008WO2008122041A2 Biased ligands for receptors such as the pth receptor
10/09/2008WO2008122037A2 Inhibitors of the ceramide metabolic pathway as adjuncts to opiates
10/09/2008WO2008121898A1 Fusion proteins with cleavable spacers and uses thereof
10/09/2008WO2008121881A2 INHIBITORS OF NF-ϰB ACTIVITY
10/09/2008WO2008121830A2 Phage receptor binding proteins for antibacterial therapy and other novel uses
10/09/2008WO2008121719A1 Method of treating ischemic disorders
10/09/2008WO2008121563A2 Modified fgf-21 polypeptides and their uses
10/09/2008WO2008121402A1 Methods and compositions for the treatment of proliferative diseases
10/09/2008WO2008121154A2 Nucleic acid sequences for biosynthesis of non -mccj25-related lariat peptides
10/09/2008WO2008121046A1 Improvement of gastric emptying in patients suffering from diabetes mellitus
10/09/2008WO2008121044A1 Ischemic disorder or disease inhibitors
10/09/2008WO2008121009A1 Modified adiponectin proteins
10/09/2008WO2008121007A1 Novel saratan polypeptides and polynucleotides and methods of use thereof
10/09/2008WO2008120801A1 Method of producing antithrombin composition
10/09/2008WO2008120741A1 Sustained release preparation of basic fibroblast growth factor
10/09/2008WO2008120240A1 Anti diabetic protein
10/09/2008WO2008120085A2 Angiogenic composition
10/09/2008WO2008119851A1 Protein product for treatment of infectious diseases and related inflammatory processes
10/09/2008WO2008119850A1 Topical formulation for treatment of ocular hypertension and glaucoma
10/09/2008WO2008119360A1 Amiloride sensitive sodium channels associated with panic disorders
10/09/2008WO2008119203A1 A purified recombinant batroxobin with high specific activity
10/09/2008WO2008119185A1 Process for the manufacture of a dairy-based anti-inflammatory composition
10/09/2008WO2008119160A1 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
10/09/2008WO2008119110A1 Treatment of obesity
10/09/2008WO2008103301A3 Treatment of the eye using macrophages and/or agents able to affect blood vessel morphology
10/09/2008WO2008100627A3 The secreted protein ccdc80 regulates adipocyte differentiation
10/09/2008WO2008100130A3 Composition containing kadok extract and collagen
10/09/2008WO2008099190A3 Osteogenic compounds
10/09/2008WO2008092644A3 Fviii-independent fix-mutant proteins for hemophilia a treatment
10/09/2008WO2008091710A3 Methods and compositions for treating neuropathies
10/09/2008WO2008091701A3 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
10/09/2008WO2008090285A3 New peptides and polypeptides with improved stability useful in the regeneration of the nervous system
10/09/2008WO2008089053A3 Gp100-specific t cell receptors and related materials and methods of use
10/09/2008WO2008086449A3 Synthetic osteopontin peptides and methods of use
10/09/2008WO2008079982A3 Liposome composition for targeting egfr receptor
10/09/2008WO2008076815A3 Pro-angiogenic peptides
10/09/2008WO2008074885A3 Process for manufacturing ophthalmic oil-in-water emulsions
10/09/2008WO2008073376A3 Porous keratin construct and method of making the same
10/09/2008WO2008067495A3 Chemotherapeutic conjugates and methods of use
10/09/2008WO2008061014A3 Self-assembling peptide amphiphiles for tissue engineering
10/09/2008WO2008054592A3 Methods for production of recombinant plasminogen and plasmin polypeptides
10/09/2008WO2008048675A3 Treatment for age-related macular degeneration and other diseases of the eye
10/09/2008WO2008038296A3 Recombinant calcitonin fused to interleukin-2
10/09/2008WO2008034116A3 Products and methods using soy peptides to lower total and ldl cholesterol levels
10/09/2008WO2008024285A3 Antibiotic compound
10/09/2008WO2008022019A3 Promiscuous her-2/neu cd4 t cell epitopes
10/09/2008WO2008019131A3 Methods and compositions for treating ige-mediated diseases
10/09/2008WO2008018933A3 Detection of protease and protease activity using a single nanocrescent sers probe
10/09/2008WO2008014400A3 Crohn disease susceptibility gene
10/09/2008WO2008008569A3 Prelamin a pre peptide as a universal stem cell differentiation signal
10/09/2008WO2008008463A3 METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPβ
10/09/2008WO2007146038A3 Albumin fusion proteins
10/09/2008WO2007130743A3 Capreomycin derivatives and their use as antibacterials
10/09/2008WO2007120457B1 Composition and method for stabilizing corneal tissue after refractive surgery
10/09/2008WO2007103009A3 CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES
1 ... 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 ... 3163